TruScreen News
Scroll down to read all the latest news articles, press releases, and interviews.
Looking for our Public Announcements? Head on over to our announcements page in the Investor Centre
ASX/NZX Announcements
TruScreen at Congress of Mexican Gynaecology and Obstetrics 2022
TruScreen's Mexican distributor, Sunbird, continues their local marketing efforts with a TruScreen booth at the 70th Congress of Mexican Gynaecology and Obstetrics in Guadalajara.
View
Emerging ASX Gems Investment Conference Presentation
TruScreen Group Limited recently presented at the Emerging ASX Gems Investment Conference by The Capital Network. Watch a recording of the presentation here.
View
TruScreen continues to make progress in key markets worldwide
NZX/ASX Announcement 15 December 2021 TruScreen Group Limited (NZX/ASX: TRU) (‘TruScreen’ or ‘the Company’) is pleased to provide a market update, outlining the Company’s progress in several of its key…
View
Tackling cervical cancer through tech innovation and global expansion
TruScreen Group Limited's (NZX/ASX: TRU) CEO Juliet Hull sits down with MarketLit's host Lelde Smits to discuss the TruScreen technology, eliminating cervical cancer and TruScreen's 2022 outlook.
View
National Cervical Cancer Awareness Week
Time to Catch Up is this year’s National Cervical Cancer Awareness Week’s theme. With the uncertainty and ongoing impacts from the COVID-19 pandemic, more women have fallen behind in keeping…
View
Wave of Health – the all-Russian Promotion
In September 2021, TruScreen’s Russian distributor, Intelmed Systems, participated in the 15th annual “Wave of Health” initiative. The annual “Wave of Health” campaign sees a ship with teams of doctors…
View
TruScreen device – milestones achieved on growth strategy
TruScreen Group Limited is pleased to announce the achievement of key milestones relating to the ongoing development of the Company’s women’s health care technology and its overseas growth strategy.
View
Clinical Trial Results Highlight Efficacy of TRU Technology
A new study, published in the European Journal of Obstetrics and Gynaecology and Reproductive Biology[1], concludes that TruScreen’s cervical cancer screening technology meets or exceeds the effectiveness of alternative cervical…
View
Zimbabwe Pilot Program Underway
The National Aids Council pilot will compare TruScreen to VIAC. VIAC is currently the common screening method for cervical cancer in the region. The NAC pilot hopes to have TruScreen…
View
TruScreen August ’21 Newsletter
Truscreen Group Limited (NZX/ASX: TRU) is pleased to provide a copy of its August 2021 Stakeholders Newsletter. This gives an update on TruScreen's performance and highlights key initiatives underway. Highlights…
View
First Sales Made in Eastern Europe
TruScreen Group Limited is pleased to advise that it has received its first order from Serbia, Eastern Europe.
View